Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Meenalochani S, Dheen ST and Tay SSW
Parkinson’s disease is a neurodegenerative disorder that results in the degeneration of dopaminergic neurons in the substantia nigra (SNc) of the midbrain. Understanding the molecular mechanisms underlying the cause of Parkinson’s disease (PD) has attracted the attention of many researchers in the last few decades. In spite of the recent technical advances in the field of neuroscience, the complete pathophysiology of PD is not fully understood. Dysregulated sphingolipid metabolism has been shown to underlie the pathophysiology of many neurodegenerative disorders. However, the role of these sphingolipids in the pathophysiology of PD is still not known. This paper focuses on the, metabolic pathways that are involved in PD pathogenesis with emphasis on sphingolipids and the possible role played by them in the pathogenesis of PD.